ANKARA: The Turkish pharmaceutical company Pharmactive explained that it has entered the European market with a drug that is developed and used to treat cardiovascular diseases. The company announced the first shipment of Europe 8217 with a million cans of drugs.
The general manager of pharmaceutical overseas markets and strategic planning, which says Turkey is mostly importing medicines from abroad, said that Turkey is now in a position to sell drugs abroad. He said y received licenses in 10 countries, including Austria, Germany, Spain, Italy, Holland, Malta, Portugal, Britain, France and Hungary, and continued: “An equivalent drug developed in our R D center. Our R D center is one of Turkey’s approved and numbered centres. It was developed as a result of a 2-year study, n license file was created and applied to European countries.
After approval process has been completed, we have completed production quality processes and are releasing m through our distributors. Our main goal is to contribute to development of Turkey by increasing pharmaceutical exports. Pharmaceutical exports are entering high-tech products status and se diseases are chronic diseases, i.e. medications that need to be used for long term. ” “2019 year in end, we will be exporting medicines in 50 countries” In export markets of its targets within 5 years, first 5 companies to come out of domestic industry, said that “we started sales in Russia, Europe and some Far East countries, Africa, Middle East. At end of 2019, we will be exporting medicines in 50 countries. We also plan to contribute to our country in pharmaceutical exports. In our R D Center, 101 products have been developed in 5 years. We have applied for 350 products to export markets. We’ve received over 100 approvals. In this way we aim to support our country by increasing our exports, “he said.
Levent Seloğlu , a member of board of Directors of company, said that in 2022 y aimed to provide at least 25 percent of total turnover in exports, in 2022 y planned to reach an export figure of around 60 million dollars in year reported. Selamoglu said earlier that Turkey has made its products to individual countries, but at same time y are excited about making a shipment of medicines to 10 European countries, adding that y added, “Drug exports to European or developed country markets It is an indication of how high quality of pharmaceutical production is, standard of advanced pharmaceutical technology in Turkey. Such beginnings will bring much larger beginnings and exports to much larger markets. In continuation of this, we hope that Turkish pharmaceutical sector will take molecules he discovers and bring to foreign markets. “
